Compositions and methods for treating and preventing autoimmune induced cardiac long QT syndrome
US11787840B2 · kind B2 · utility
0Cited by
0References
5Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Aug 21, 2020 |
| Grant date | Oct 17, 2023 |
| Priority date | — |
| Expiry date | Aug 21, 2040 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K39/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Disclosed herein, are decoy peptides or polypeptides capable of neutralizing and/or inhibiting the binding of anti-Ro antibodies to a hERG potassium channel extracellular pore region, and pharmaceutical compositions containing the decoy peptides or polypeptides and methods of use.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.